• Product nameAnti-BCAR3 antibody
    See all BCAR3 primary antibodies
  • Description
    Rabbit polyclonal to BCAR3
  • Tested applicationsSuitable for: IHC-P, WB, ELISA, ICC/IFmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide derived from the C-terminal of human BCAR3.

  • Positive control
    • Human colon carcinoma tissue. Extracts from HeLa, Jurkat and HUVEC cells.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 50% Glycerol, PBS, 150mM Sodium chloride, pH 7.4
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab65111 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/50 - 1/100.
WB 1/500 - 1/1000. Detects a band of approximately 93 kDa (predicted molecular weight: 93 kDa).
ELISA 1/10000.
ICC/IF Use a concentration of 1 µg/ml.


  • FunctionMay act as an adapter protein and couple activated growth factor receptors to a signaling pathway that regulates the proliferation in breast cancer cells. When overexpressed, it confers anti-estrogen resistance in breast cancer cell lines. May also be regulated by cellular adhesion to extracellular matrix proteins.
  • Tissue specificityUbiquitously expressed. Found in several cancer cell lines, but not in nonmalignant breast tissue.
  • Sequence similaritiesContains 1 Ras-GEF domain.
    Contains 1 SH2 domain.
  • Information by UniProt
  • Database links
  • Alternative names
    • BCAR 3 antibody
    • BCAR3 antibody
    • BCAR3_HUMAN antibody
    • Breast cancer anti estrogen resistance 3 antibody
    • Breast cancer anti estrogen resistance protein 3 antibody
    • Breast cancer anti-estrogen resistance protein 3 antibody
    • Breast cancer antiestrogen resistance 3 antibody
    • dJ1033H22.2 antibody
    • dJ1033H22.2 breast cancer anti estrogen resistance 3 antibody
    • dJ1033H22.2 breast cancer antiestrogen resistance 3 antibody
    • KIAA0554 antibody
    • Novel SH2 containing protein 2 antibody
    • Novel SH2-containing protein 2 antibody
    • NSP 2 antibody
    • NSP2 antibody
    • SH2 containing protein Nsp2 antibody
    • SH2 domain containing protein 3B antibody
    • SH2 domain-containing protein 3B antibody
    • SH2D3B antibody
    see all

Anti-BCAR3 antibody images

  • Immunohistochemistry analysis of paraffin-embedded human colon carcinoma tissue stained with BCAR3 antibody (ab65111) at 1/50 - 1/100 dilution, with (right) and without (left) the immunising peptide.
  • All lanes : Anti-BCAR3 antibody (ab65111) at 1/500 dilution

    Lane 1 : extracts from HeLa cells
    Lane 2 : extracts from Jurkat cells
    Lane 3 : extracts from HUVEC cells
    Lane 4 : extracts from HUVEC cells with immunising peptide at 5 µg

    Lysates/proteins at 5 µg per lane.

    Predicted band size : 93 kDa
    Observed band size : 93 kDa
  • ICC/IF image of ab65111 stained MCF7 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab65111, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-BCAR3 antibody (ab65111)

ab65111 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab65111.
Please use the links above to contact us or submit feedback about this product.